Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JBLU vs GSK✓SelectedUSD · GSKJBLU vs GSK performance historyLatest closeAs of-3.08%11/19
Stock and ETF performance explorer

JBLU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.4%
GSK return
+53.5%
Excess return
-74.9%
Maximum drawdown
-70.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.1%-1.6%-1.5%-2.7%
7D-9.2%-4.7%-4.5%-8.0%
30D+18.9%-4.7%+23.6%+20.3%
3M-29.4%-8.8%-20.6%-27.7%
6M-21.0%-4.6%-16.4%-20.3%
YTD-24.0%+1.0%-24.9%-22.6%
1Y-15.6%+6.9%-22.5%-14.6%
All-21.4%+53.5%-74.9%-17.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling